Navigation Links
CASI Pharmaceuticals Reports Second Quarter 2014 Financial Results
Date:8/14/2014

2013Total revenues

$
-

$
-
Research and development

$
724,493

$
836,582
General and administrative

$
891,917

$   1,015,701Net loss

$ (1,616,410)

$   (1,851,840)Net loss per share attributable to

common shareholders (basic and diluted)

 

$
(0.06)

$
(0.07)
Weighted average number of

shares outstanding (basic and diluted)

 

27,040,429

 

27,023,038Cash and cash equivalents

$13,079,745

$17,222,918 Six Months Ended June 30,2014

2013Total revenues

$
-

$
-
Research and development

$
,284,467

$
,342,957
General and administrative

$
,783,292

$   1,645,603Net loss

$ (3,067,759)

$   (2,987,727)Net loss per share attributable to

common shareholders (basic and diluted)

 

$
(0.11)

 

$
(0.12)
Weighted average number of

shares outsta
'/>"/>

SOURCE CASI Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Immune Pharmaceuticals Announces Second Quarter 2014 Financial Results and Provides Update on Bertilimumab Commencement of Phase II Clinical Trials
2. Imprimis Pharmaceuticals Announces Second Quarter 2014 Financial Results and Provides Operational Update
3. Dipexium Pharmaceuticals Reports Second Quarter 2014 Financial and Operational Results
4. Valeant Pharmaceuticals Receives FTC Second Request Under Hart-Scott-Rodino
5. Rock Creek Pharmaceuticals Reports Second Quarter and Announces Clinical Update
6. AcelRx Pharmaceuticals Reports Second Quarter 2014 Financial Results
7. Inovio Pharmaceuticals Reports 2014 Second Quarter Financial Results
8. Absorption Pharmaceuticals CEO Jeff Abraham Discusses Promescent on KFI
9. Global Diabetic Neuropathy Market 2014-2018: Key Vendors are Eli Lilly and Co, Janssen Pharmaceuticals and Pfizer Inc.
10. Jazz Pharmaceuticals Announces Pricing of $500 Million of Exchangeable Senior Notes
11. AcelRx Pharmaceuticals to Participate in Three Upcoming Investor Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that the ... Lixte,s lead compound, LB‑100, is being conducted, has been expanded ... Kovach , M.D., the founder and President of Lixte, said ... a single site. Accrual of patients, however, was slower than ...
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ ... its CytoSorb® extracorporeal cytokine adsorber to reduce deadly ... the receipt of $385,642, net of transaction costs, ... the Technology Business Tax Certificate Transfer Program sponsored ...
(Date:1/23/2015)... BOSTON , January 23, 2015 Heptares ... is delighted to announce that the Malcolm Campbell ... Congreve (Vice President of Chemistry), Fiona Marshall ... (Chief Executive Officer and co-founder) for the seminal contributions to ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4
... 2007 - OXiGENE, Inc.,(NASDAQ: OXGN, XSSE: OXGN), a ... and eye,diseases, announced today the publication of two ... afternoon at the,Annual Meeting of the American Society ... abstract reports for the first time full data ...
... Presented at Annual Meeting of the American Society ... June 4, 2007 -- SciClone Pharmaceuticals,Inc. (Nasdaq:SCLN) and ... thymalfasin (ZADAXIN(r), thymosin,alpha 1) achieved its primary endpoint ... with stage IV malignant melanoma, the,most advanced form ...
Cached Medicine Technology:OXiGENE Abstracts Published in ASCO Program 2OXiGENE Abstracts Published in ASCO Program 3OXiGENE Abstracts Published in ASCO Program 4
(Date:1/22/2015)... 2015 Padre Murphy's and Owner Tom Boyle ... Pro Player Health Alliance (PPHA). The PPHA's passion for ... everyone, including NFL greats, treated for obstructive sleep apnea (OSA) ... supporting the cause in the valley. The most recent plans ...
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, has recently ... View website of AngelWeddingDress.com to find more details. ... online for a bridal party. AngelWeddingDress offers a variety ... Its maternity wedding dresses are specially designed for 2015. ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining the ... . , Auto insurance quotes help many drivers find ... necessary to call an agent or visit an agency for ... single website: http://autocarinsurancebest.com/ . , Every business who relies ...
(Date:1/22/2015)... 2015 Yesterday, Senator Holly Mitchell ... Kristin Olsen (R-Modesto) were honored by the California ... biotechnology, biomedical science, medical device and pharmaceutical innovation ... the “2014 Life Sciences Champion” award from CHI ...
(Date:1/22/2015)... 22, 2015 EBSCO Information Services ... expanding their relationship in an effort to further promote visibility ... While EBSCO has long made AMA journals available via its ... for The JAMA Network. , Long known as ...
Breaking Medicine News(10 mins):Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
... about microRNAs short strands of RNA that can ... it becomes how closely they are associated with cancer. ... and their colleagues have identified two microRNAs (miRNAs) that ... miRNAs may provide an early warning of metastatic breast ...
... findings apply to humans , , MONDAY, Jan. 28 (HealthDay News) ... a new study found. , The mice that were breast-fed ... the allergen and developed tolerance to it. , But once ... can be extrapolated to humans. , "You hate to ...
... 28 MaxCyte, Inc., a,clinical-stage therapeutic company ... systems, announces that Madhusudan V. Peshwa, Ph.D., ... present on Tuesday,January 29, 2008, at 11:35 ... Therapy,Forum in Washington, DC. Dr. Peshwa,s presentation ...
... of,President Bush,s final State of the Union address this ... that,should be undertaken this year to protect our nation,s ... unstable economy, the growing health,care crisis and very real ... on the president and Congress to:, -- Increase ...
... A new study, led by researchers at The ... that certain over-the-counter earwax softeners can cause severe inflammation ... results of the study, recently published in The Laryngoscope, ... , Patients often complain that wax is blocking their ...
... Preventive Medicine (ACPM) has found there is insufficient ... prostate screening with digital rectal examination (DRE) or ... (PSA). ACPM advises that clinicians caring for ... family history, should provide information about the potential ...
Cached Medicine News:Health News:2 microRNAs promote spread of tumor cells 2Health News:2 microRNAs promote spread of tumor cells 3Health News:Breast-Feeding Protected Mice From Asthma 2Health News:Breast-Feeding Protected Mice From Asthma 3Health News:MaxCyte to Present at the Phacilitate Cell and Gene Therapy Forum 2008 2Health News:APHA Says Investing in Healthy People and Communities Can Help Create a Healthy Economy 2
... Designed and manufactured specifically ... MultiWash II delivers the ... demand. The MultiWash II ... dependable accuracy, while providing ...
... the determination of A1c is also designed to ... is a fully automated analyzer including primary tube ... in safety and positive identification. The analysis methodology ... be interference-free and to produce the lowest CV's ...
Micromat II Hemoglobin A1c instrument is an easy-to-use, accurate and precise instrument with an requirement of only 10 L of capillary or venous sample....
... Cascade M-4 is a manual hemostasis ... routine clotting assays - PTs, aPTTs, ... for easy, inexpensive, low-volume testing, this ... big on features, offering time and ...
Medicine Products: